Showing results (121-130 of 352) with videos related to

Sort By:
Pageof 36
Plos One|April 1, 2021
Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysisDominic Pilon, Kruti Joshi, John J Sheehan, et al.
Critical Care (London, England)|June 8, 2007
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort studyMarya D Zilberberg, Chureen Carter, Patrick Lefebvre, et al.
Journal of Medical Economics|February 29, 2024
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United StatesDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Journal of Comparative Effectiveness Research|August 16, 2017
Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefitsKruti Joshi, Marie-Hélène Lafeuille, Rhiannon Kamstra, et al.
Journal of Women'S Health (2002)|February 25, 2012
Cost burden and treatment patterns associated with management of heavy menstrual bleedingJeffrey T Jensen, Patrick Lefebvre, François Laliberté, et al.
Current Medical Research and Opinion|February 11, 2021
Medication patterns of abiraterone acetate plus prednisone or enzalutamide and PSA progression in veterans with metastatic castration-resistant prostate cancerStephen J Freedland, Sophia Li, Dominic Pilon, et al.
Current Medical Research and Opinion|March 5, 2008
Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian settingJacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis, et al.
Journal of Medical Economics|January 6, 2022
The societal economic value of COVID-19 vaccines in the United StatesNoam Kirson, Elyse Swallow, Jessica Lu, et al.
Future Science OA|July 12, 2025
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myelomaMatthew J Pianko, Niodita Gupta-Werner, Bruno Emond, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumabMaryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, et al.
Pageof 36